Prevention and treatment of relapse after stem cell transplantation with immunotherapy

  • Nicola Gökbuget
  • Jonathan Canaani
  • Arnon Nagler
  • Michael Bishop
  • Nicolaus Kröger
  • David Avigan


Relapse has become the leading cause of treatment failure after stem cell transplantation. Besides cellular therapies and novel agents, immunotherapeutic strategies have entered clinical practice in order to reduce or prevent relapse. Here, we summarize the presentations on checkpoint inhibitors, vaccination strategies, and novel antibody therapies, which were presented and discussed at the third International Workshop on Biology, Prevention, and Treatment of Relapse after Stem Cell Transplantation.

Bibliografische Daten

StatusVeröffentlicht - 06.2018
PubMed 29795427